Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rifampin drug interactions.

A M Baciewicz, T H Self

    Archives of Internal Medicine
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Rifampin, an antituberculosis drug, can interact with many medications by speeding up their metabolism. This potent enzyme inducer may affect drugs like anticoagulants and oral contraceptives, requiring careful monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical management.

    Journal of clinical pharmacy and therapeutics·2017
    Same author

    Are there gender differences in the use of peak flow meters?

    The Journal of asthma : official journal of the Association for the Care of Asthma·2001
    Same author

    Bleeding associated with doxycycline and warfarin treatment.

    Archives of internal medicine·2001
    Same author

    Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

    Drugs·2001
    Same author

    Studies demonstrating improved outcomes in patients with asthma: a 10-year review.

    The American journal of managed care·2001
    Same author

    Hospital admission due to warfarin potentiation by TMP-SMX.

    The Nurse practitioner·2001
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Pharmacology
    • Hepatology
    • Infectious Diseases

    Background:

    • Rifampin is a key antituberculosis agent, typically used in combination therapy for 9-12 months.
    • Its potent induction of drug metabolism presents a significant risk for drug interactions.
    • Rifampin influences hepatic cytochrome P-450 content and endoplasmic reticulum proliferation.

    Purpose of the Study:

    • To review the known and potential drug interactions associated with rifampin.
    • To highlight rifampin's mechanism as a potent inducer of drug-metabolizing enzymes.
    • To underscore the clinical significance and areas for future research regarding rifampin interactions.

    Main Methods:

    • Review of existing studies and case reports on rifampin drug interactions.
    • Analysis of rifampin's known effects on hepatic drug metabolism pathways.

    Related Experiment Videos

  • Examination of rifampin's impact on the absorption and hepatic uptake of other drugs.

    • Main Results:

    • Rifampin accelerates the metabolism of numerous drugs, including oral anticoagulants, oral contraceptives, glucocorticoids, digitoxin, quinidine, methadone, hypoglycemics, and barbiturates.
    • The enzyme-induction effect of rifampin is selective, making interaction outcomes variable.
    • Potential alterations in drug absorption and hepatic uptake by rifampin are also noted.

    Conclusions:

    • Rifampin is a potent inducer of drug metabolism, leading to significant drug interactions.
    • Clinical importance of some rifampin interactions requires further investigation.
    • Future research is expected to uncover additional rifampin-related drug interactions and their clinical implications.